Details for Patent: 9,555,001
✉ Email this page to a colleague
Which drugs does patent 9,555,001 protect, and when does it expire?
Patent 9,555,001 protects JENTADUETO XR and is included in one NDA.
Protection for JENTADUETO XR has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has sixteen patent family members in sixteen countries.
Summary for Patent: 9,555,001
| Title: | Pharmaceutical composition and uses thereof |
| Abstract: | The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and/or a SGLT-2 inhibitor drug, and metformin XR, processes for the preparation thereof, and their use to treat certain diseases. |
| Inventor(s): | Ito; Masanori (Hyogo, JP), Egusa; Kenji (Biberach an der Riss, DE), Kleinbeck; Kyle (Brooklyn, NY), Messerschmid; Roman (Ulm, DE), Schneider; Peter (Ulm-Einsingen, DE), Voleti; Venkata (Mason, OH) |
| Assignee: | Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE) |
| Application Number: | 13/785,365 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Compound; Dosage form; |
More… ↓ |
Drugs Protected by US Patent 9,555,001
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Boehringer Ingelheim | JENTADUETO XR | linagliptin; metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 208026-001 | May 27, 2016 | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
| Boehringer Ingelheim | JENTADUETO XR | linagliptin; metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 208026-002 | May 27, 2016 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,555,001
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 090269 | ⤷ Subscribe | |||
| Australia | 2013229538 | ⤷ Subscribe | |||
| Canada | 2866421 | ⤷ Subscribe | |||
| Chile | 2014002325 | ⤷ Subscribe | |||
| China | 104220049 | ⤷ Subscribe | |||
| Eurasian Patent Organization | 201400986 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
